http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2977048-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66996dcf2dc59f595b8c0584986d50b3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
filingDate 2014-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae27f40a57fda44812b706194db5535b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2f032008755e37b17a4093ed6ad6840
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_335569007a74abfa7f2f6b6ffdc1ccaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10dcebd4fba1a0603d5b9f2f2c658b7b
publicationDate 2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2977048-A1
titleOfInvention Complex preparation including valsartan and rosuvastatin calcium and manufacturing method therefor
abstract The present invention relates to a pharmaceutical composition including valsartan and rosuvastatin calcium as active ingredients, and a manufacturing method therefor. The pharmaceutical composition including valsartan and rosuvastatin calcium according to the present invention can alleviate side effects of the existing single preparations and simultaneously improve compliance of patients having a cardiovascular disease, a hyperlipidemic disease and a complex disease thereof, and increases treatment and prevention effects, and in particular, obtains synergistic effects in treating hyperlipidemia, and enhances the dissolution rate of valsartan and rosuvastatin calcium and treatment effects by granulating valsartan and mixing rosuvastatin calcium.
priorityDate 2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12245
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID751795
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731092
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14847
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO19062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059198
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450470952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48199
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02742
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19094
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394949
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23623894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6439133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394850
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ07203

Total number of triples: 86.